High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.
about
Mast Cell Clonal Disorders: Classification, Diagnosis and ManagementLong-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Systemic mastocytosis: a rare cause of single vertebral body uptake on bone scan.Bone Health in Patients With Hematopoietic Disorders of Bone Marrow Origin: Systematic Review and Meta- Analysis.Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.Failure to generate bone marrow adipocytes does not protect mice from ovariectomy-induced osteopenia.Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study.Bone morbidity in chronic myeloproliferative neoplasms.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Endocrine manifestations of systemic mastocytosis in bone.Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis.Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study.Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.Osteoporotic spinal burst fracture in a young adult as first presentation of systemic mastocytosis.Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.Targeted Treatment Options in Mastocytosis.Systemic Mastocytosis With Decreased Bone Density and Fractures.Systemic mastocytosis associated with severe osteoporosis in a male patient.Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H(+) /K(+) ATPase Beta Subunit KO Mice.Mast Cells Are Critical Regulators of Bone Fracture-Induced Inflammation and Osteoclast Formation and Activity.
P2860
Q28070386-99729E93-4F02-4859-8E49-BE6DDDD6D298Q35153623-9ECC9621-1972-45AB-B5E3-56FD8476C0BEQ35346111-5EEE71D9-7C9E-475B-985E-29B4954D3B43Q36175940-724A6FBF-C171-4E75-A2E0-7C93740FCBA2Q36218356-3864C9D2-5B2E-41A9-A2EA-AFF3F054992DQ36588295-24D17229-0222-4306-9454-89B65749ECE4Q38424081-33133965-6A16-4C08-A873-6ED79D5173B8Q38513219-A8E0D64E-2DB3-4CC6-B0FF-C63ED0C92041Q38739710-B3171D60-27E9-4BC9-A3EB-272AE8A0DD46Q38848019-2000C14C-3567-4700-8324-03F60D34867BQ40241700-F1BC8B70-9732-403C-90ED-CC6595E3B70DQ40533819-928AF21B-CDF8-4C43-9063-AA5A6C6C0F19Q40544293-0B7CEEDC-3068-4C7D-8E5D-6A5F55B096ECQ40871762-AB0DF94A-0AC5-42B4-8B1F-93D8B6CECD4BQ40978238-F63FA852-A35A-4BAD-B454-E6E9085FEF90Q41061871-FF91DDF4-A549-4F46-8832-A1E4D3AE7274Q41121492-5D79F384-3DBB-4603-AC21-FD562EE06DB3Q45925284-DA36117C-A1CF-41BB-8553-202CEECDCFFEQ46287428-9A6035AF-8797-4C01-A526-068F8EC58720Q50871797-958E18A4-6B68-41E8-B22D-EB806353F2B1Q50931979-FAD1034F-270C-4B9E-AA78-A52F079699A8Q53125405-B254247D-7D80-478D-A309-6659C0F71AC4
P2860
High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@en
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@nl
type
label
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@en
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@nl
prefLabel
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@en
High prevalence of fractures a ...... ndolent systemic mastocytosis.
@nl
P2093
P2860
P1433
P1476
High prevalence of fractures a ...... indolent systemic mastocytosis
@en
P2093
J G R de Monchy
J J van Doormaal
W van der Goot
P2860
P304
P356
10.1111/J.1398-9995.2011.02780.X
P577
2012-01-09T00:00:00Z